Compounds > cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
Page last updated: 2024-09-03

cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Cytomegalovirus

cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine has been researched along with Cytomegalovirus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW1
Borysko, KZ; Breitenbach, JM; Collins, M; Drach, JC; Hilfinger, JM; Kashemirov, BA; Krylov, IS; McKenna, CE; Peterson, LW; Serpi, M; Zakharova, VM1
Bernstein, DI; Bourne, N; Bravo, FJ; Schleiss, MR1
Bernstein, DI; Bravo, FJ; Cardin, RD1
Andrei, G; De Clercq, E; Neyts, J; Schols, D; Snoeck, R1

Other Studies

5 other study(ies) available for cyclic-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and Cytomegalovirus

ArticleYear
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
    Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13

    Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine

2011
Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Adenine; Animals; Antiviral Agents; Area Under Curve; Biological Availability; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cidofovir; Cowpox virus; Cytomegalovirus; Cytosine; Fibroblasts; Herpesvirus 1, Human; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Molecular Structure; Organophosphonates; Prodrugs; Rats; Tyrosine; Vaccinia virus

2011
An animal model of neonatal cytomegalovirus infection.
    Antiviral research, 2003, Volume: 60, Issue:1

    Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Brain; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Guinea Pigs; Liver; Lung; Organophosphorus Compounds; Spleen; Virus Replication

2003
Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
    The Journal of infectious diseases, 2006, Feb-15, Volume: 193, Issue:4

    Topics: Animals; Animals, Newborn; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Guinea Pigs; Immunity, Maternally-Acquired; Infectious Disease Transmission, Vertical; Organophosphorus Compounds; Pregnancy; Pregnancy Outcome; Virus Replication

2006
Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Antiviral research, 1991, Volume: 16, Issue:1

    Topics: Adenine; Antiviral Agents; Cell Line; Cidofovir; Cytomegalovirus; Cytosine; Flow Cytometry; Ganciclovir; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Viral Plaque Assay

1991